Dr. X wurde 1974 in Bulgarien geboren und spricht Englisch, Russisch und Bulgarisch. Er absolvierte sein Medizinstudium an der Hacettepe Medical School (1993-1999). Anschließend absolvierte er seine Facharztausbildung an der Augenklinik des Göztepe Training and Research Hospital Clinic of Ophthalmology (2000-2004). Er war außerordentlicher Professor am Ausbildungs- und Forschungskrankenhaus der Medeniyet-Universität Göztepe und Chefarzt der Augenklinik des Ausbildungs- und Forschungskrankenhauses der Medeniyet-Universität Göztepe (2014-2016) und Leiter der Abteilung für vitreoretinale Chirurgie am Ausbildungs- und Forschungskrankenhaus der Medeniyet-Universität Göztepe (2010). -2017). Derzeit arbeitet er in der Abteilung für vitreoretinale Chirurgie des Dünyagöz-Krankenhauses (seit 2017). Er ist Mitglied der türkischen Ärztekammer, der türkischen Gesellschaft für Augenheilkunde, der türkischen republikanischen Gesellschaft für Augenheilkunde und der türkischen Gesellschaft für Augenheilkunde, Abteilung für vitreoretinale Chirurgie. Er hat 17.000 Kataraktoperationen und 8.500 vitreoretinale Operationen durchgeführt.
Mehr lesenDr. X wurde 1974 in Bulgarien geboren und spricht Englisch, Russisch und Bulgarisch. Er absolvierte sein Medizinstudium an der Hacettepe Medical School (1993-1999). Anschließend absolvierte er seine Facharztausbildung an der Augenklinik des Göztepe Training and Research Hospital Clinic of Ophthalmology (2000-2004). Er war außerordentlicher Professor am Ausbildungs- und Forschungskrankenhaus der Medeniyet-Universität Göztepe und Chefarzt der Augenklinik des Ausbildungs- und Forschungskrankenhauses der Medeniyet-Universität Göztepe (2014-2016) und Leiter der Abteilung für vitreoretinale Chirurgie am Ausbildungs- und Forschungskrankenhaus der Medeniyet-Universität Göztepe (2010). -2017). Derzeit arbeitet er in der Abteilung für vitreoretinale Chirurgie des Dünyagöz-Krankenhauses (seit 2017). Er ist Mitglied der türkischen Ärztekammer, der türkischen Gesellschaft für Augenheilkunde, der türkischen republikanischen Gesellschaft für Augenheilkunde und der türkischen Gesellschaft für Augenheilkunde, Abteilung für vitreoretinale Chirurgie. Er hat 17.000 Kataraktoperationen und 8.500 vitreoretinale Operationen durchgeführt.
Education :
Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010
Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011
Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016
Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012
Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021
Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present
Educational Qualifications :
1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination passed on April 2017
2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017
3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018
4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.
5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.
6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.
7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.
Presentations & Posters :
1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey.
2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey
3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France
4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.
5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.
6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.
7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey
8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey
9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey
12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey
13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey
14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey
17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France
18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey
19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey
20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey
23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey
24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.
Work Experience :
1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)
5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)
Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present
Mehr lesen
Education :
Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010
Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011
Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016
Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012
Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021
Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present
Educational Qualifications :
1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination passed on April 2017
2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017
3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018
4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.
5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.
6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.
7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.
Presentations & Posters :
1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey.
2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey
3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France
4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.
5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.
6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.
7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey
8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey
9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey
12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey
13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey
14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey
17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France
18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey
19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey
20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey
23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey
24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.
Work Experience :
1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)
5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)
Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present
He has published a large number of scientific articles that have entered international scientific indexes. There are many oral and poster presentations to national and international scientific meetings. He is an active member of the Turkish Ophthalmology Association (TOD), the American Academy of Ophthalmology Association and the European Society of Cataract and Refractive Surgeons. He won the European Ophthalmology Qualification Exam (European Board of Ophthalmology) and became a FEBO.
Opr, who is married and has 1 child. Dr. Hüseyin Aslankara speaks English well.
Special interests:
Retinal Diseases and Vitreoretinal Surgery
Cataract Surgery (multifocal, trifocal, toric intraocular lenses)
Cataract Surgery with Laser (Femtosecond Laser Cataract)
Excimer Laser Surgeries (Lasik, Lasek, PRK)
Strabismus Treatment and Surgery
Children's Eye Diseases
Eye Pressure (Glaucoma) Treatment and Operations
Retinopathy of Prematurity and Its Treatment
Eyelid Surgeries
He has published a large number of scientific articles that have entered international scientific indexes. There are many oral and poster presentations to national and international scientific meetings. He is an active member of the Turkish Ophthalmology Association (TOD), the American Academy of Ophthalmology Association and the European Society of Cataract and Refractive Surgeons. He won the European Ophthalmology Qualification Exam (European Board of Ophthalmology) and became a FEBO.
Opr, who is married and has 1 child. Dr. Hüseyin Aslankara speaks English well.
Special interests:
Retinal Diseases and Vitreoretinal Surgery
Cataract Surgery (multifocal, trifocal, toric intraocular lenses)
Cataract Surgery with Laser (Femtosecond Laser Cataract)
Excimer Laser Surgeries (Lasik, Lasek, PRK)
Strabismus Treatment and Surgery
Children's Eye Diseases
Eye Pressure (Glaucoma) Treatment and Operations
Retinopathy of Prematurity and Its Treatment
Eyelid Surgeries
Prof. Cem Meschi ist Augenchirurg an der Medicana Atasehir Clinic in Istanbul, Türkei. Er ist spezialisiert auf Augenlaserkorrektur, Blepharoplastik und chirurgische Eingriffe bei Augenkrankheiten.
Prof. Cem Meschi ist Augenchirurg an der Medicana Atasehir Clinic in Istanbul, Türkei. Er ist spezialisiert auf Augenlaserkorrektur, Blepharoplastik und chirurgische Eingriffe bei Augenkrankheiten.
Specialisation:Eye CARE
Years of Experience: 13
Education: Dicle University Faculty of Medicine (2009)
Languages:English, Turkish
Memberships & Awards:Over 100 medical articles
Mehr lesenSpecialisation:Eye CARE
Years of Experience: 13
Education: Dicle University Faculty of Medicine (2009)
Languages:English, Turkish
Memberships & Awards:Over 100 medical articles
Op. Dr. Mustafa İşlek was born in 1961. After completing his medical education at Istanbul University Cerrahpaşa Faculty of Medicine, he completed his ophthalmology residency at Sakarya State Hospital. Op. Dr. İşlek was at Albert Szent Gyorgyi University Faculty of Medicine between 1990 and 1992; Between 1992 and 1994, at Istanbul Şişli Eftal Hospital; Between 1998 and 2011, he worked at Antalya Serik State Hospital. He speaks English.
Mehr lesenOp. Dr. Mustafa İşlek was born in 1961. After completing his medical education at Istanbul University Cerrahpaşa Faculty of Medicine, he completed his ophthalmology residency at Sakarya State Hospital. Op. Dr. İşlek was at Albert Szent Gyorgyi University Faculty of Medicine between 1990 and 1992; Between 1992 and 1994, at Istanbul Şişli Eftal Hospital; Between 1998 and 2011, he worked at Antalya Serik State Hospital. He speaks English.
1972-1979 Hacettepe University Faculty of Medicine
Work experiences:
Antalya Medstar Hospital 2019 / 2020
1987/2019 Antalya Akdeniz University Faculty of Medicine
Faculty Member,
glaucoma,
Glaucoma Surgery,
Cataract Surgery (Adult, Congenital),
Pterygium Surgery,
Corneal transplant (Keratoplasty)
Head of Department of Ophthalmology for two terms,
Responsibility of the cornea unit (9 years)
Glaucoma unit responsibility (20 years)
Turkish Ophthalmology Association Glaucoma Unit Board Member (3 terms)
Turkish Ophthalmology Association Ocular Infections Unit Presidency
President of Turkish Ophthalmology Association Konya-Antalya Branch (1 term)
Professional Memberships:
Turkish Ophthalmology Association
American Society of Ophthalmology
Turkish Ophthalmology Association, Glaucoma Unit active membership
Turkish Ophthalmology Association Cataract-Refraction Surgery Unit active membership
Turkish Ophthalmology Association Ocular Infections Unit active membership
Foreign language:
English
Mehr lesen1972-1979 Hacettepe University Faculty of Medicine
Work experiences:
Antalya Medstar Hospital 2019 / 2020
1987/2019 Antalya Akdeniz University Faculty of Medicine
Faculty Member,
glaucoma,
Glaucoma Surgery,
Cataract Surgery (Adult, Congenital),
Pterygium Surgery,
Corneal transplant (Keratoplasty)
Head of Department of Ophthalmology for two terms,
Responsibility of the cornea unit (9 years)
Glaucoma unit responsibility (20 years)
Turkish Ophthalmology Association Glaucoma Unit Board Member (3 terms)
Turkish Ophthalmology Association Ocular Infections Unit Presidency
President of Turkish Ophthalmology Association Konya-Antalya Branch (1 term)
Professional Memberships:
Turkish Ophthalmology Association
American Society of Ophthalmology
Turkish Ophthalmology Association, Glaucoma Unit active membership
Turkish Ophthalmology Association Cataract-Refraction Surgery Unit active membership
Turkish Ophthalmology Association Ocular Infections Unit active membership
Foreign language:
English